MOTS-c Near Me: No Local Price, $1.88 per 500 mcg

Local results for an unapproved research compound fall into five recognisable groups, and only one of them involves MOTS-c at all.

The first two rows account for most of the map. They rank for the search because they sell things in the same conceptual neighbourhood, not because they hold the compound. The fourth row is the one that occasionally does have vials, and it is also the one with the least documentation behind it.

The barrier is not licensing appetite or local regulation. It is that the product does not exist in any regulator's records.

Dispensing runs through an authorised product. Authorisation brings a marketing licence, a labelled indication, a national drug code and a legitimate wholesale channel. A search of the FDA approved drugs database returns no MOTS-c entry, and there is no EMA or MHRA authorisation either. A clinic cannot buy it from a licensed distributor because no licensed distributor carries it.

Compounding does not fill the gap. A compounding pharmacy works from approved drug products or from bulk substances meeting statutory conditions, against a prescription for an identified patient. MOTS-c is none of those things, so preparing it would be manufacturing an unapproved drug rather than compounding. Our page on buying without a prescription works through that framework in detail.

So when a local operation does hold vials, the honest description is that they bought research material from the same online suppliers you can buy it from, and are reselling it with a service wrapped around it. That is worth knowing before you treat a clinic setting as a form of quality control. It is not one.

Clinics advertising mitochondrial or cellular energy services are usually selling something real. It is simply not this molecule.

• NAD+ infusions. A dinucleotide involved in cellular redox chemistry. Not a peptide, not MOTS-c, and administered by a completely different route.
• NMN or NR supplementation. NAD+ precursors taken orally. Again a different compound class.
• Vitamin and mineral infusions. Marketed under energy and recovery language that overlaps heavily with mitochondrial peptide copy.
• Compounded peptide therapy. Where this exists it typically involves compounded incretins or other substances that a pharmacy can lawfully prepare. MOTS-c is not among them.

The overlap in vocabulary is the whole problem. MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, characterised by Lee and colleagues in Cell Metabolism in 2015 as acting through AMPK, in cells and in mice. "Mitochondrial" on a clinic menu describes a marketing category. It does not identify a molecule, and the two should not be read as the same claim.

If a clinic does specifically name MOTS-c, the questions are the same ones you would ask an online supplier: which batch, tested by which laboratory, and can you see the certificate. A consultation room does not answer any of them.

The supply that exists is online research suppliers shipping to your address, which for most US buyers is faster than arranging anything local anyway.

There is one SKU, MOTS-C at 10 mg, listed at $75.00 and $37.50 with the code PEPTIDEDECK. Orders placed before 2pm CST are dispatched the same day, and free carriage starts at $250, which one discounted vial does not reach. The material arrives as lyophilised powder with a batch number you can check against a published certificate. Ascension publishes two per batch, from Kovera Labs (batch #24-05260628) and MZ Biolabs (batch #24-01260229).

That is the entire route. Our sibling guides go deeper on each step: the ordering sequence, how suppliers score against a stated methodology, and what a legitimate checkout looks like. The compound is not for human consumption, and no amount of local convenience changes that.

Local offers are usually quoted per session or per administration, which makes them impossible to compare until you convert them into the same units as a vial. The conversion takes one line.

Reconstituted with 2 mL of bacteriostatic water the vial is 5 mg/mL, 200 units on a U-100 barrel, and 10 units draws 500 mcg. So whatever a local operation charges for a single administration, $1.88 of it is the compound. The rest is the room, the appointment, the consumables and the margin.

That is not an accusation. Services cost money and clinics have overheads. It is simply the arithmetic you need in order to know what you are being charged for, and it is the same arithmetic our price breakdown applies to the vial itself. A local quote is not a price for MOTS-c. It is a price for a service that includes a small quantity of MOTS-c, and the second number is knowable in advance.

The instinct behind a "near me" search is usually about freshness: cold chain, short transit, nothing sitting in a van. For a lyophilised peptide that instinct is aimed at the wrong stage.

Dry powder in a sealed vial is the stable form, which is exactly why research peptides ship that way rather than in solution. The vulnerable stage is not the journey, it is what happens after the water goes in, and that stage happens at your address regardless of how far the vial travelled.

So the checks that matter are the ones on arrival, not the ones on the map. Look for an intact crimp and stopper, a dry cake or film rather than anything moist, and a lot number that matches the certificate. Bring the vial to room temperature before reconstituting so condensation does not form inside it, add diluent down the wall of the glass, and swirl rather than shake. Then write the date and the volume on the vial, because a reconstituted vial with no volume written on it is an unknown concentration within a week.

Our storage guide covers handling for lyophilised material and solutions, and the reconstitution guide covers the mechanics. Neither of them gets easier because the supplier was ten miles away.

If a local seller does have vials, these are the signals that separate resold research material with a paper trail from something you should not buy at any price.

• Pre-drawn syringes or pre-mixed solution. You cannot verify what is in them, when they were made, or at what concentration. Research material arrives as dry powder.
• No batch number on the vial. Without one, no certificate can apply to it and the 10 mg on the label is an unsupported claim.
• A certificate for a different batch. Common, and usually presented as if it settles the question. It does not.
• Human-use claims or a dosing protocol. A seller describing a research compound as a treatment is either uninformed or misdescribing the product, and both bear on whether the mass is real.
• Cash only, no invoice. No record means no recourse, which matters more here than the price does.
• "Pharmaceutical grade" with no document. The phrase has no regulatory meaning on an unapproved compound. A named laboratory, an HPLC purity figure and a mass spectrometry identity result do.

Weighed against $37.50 for a documented vial shipped the same day, a local offer has to be doing something genuinely useful to be worth the missing paperwork. Convenience alone is not it. Our supplier checklist applies the same tests to online sellers, and the retatrutide version of this page reaches the same conclusion from a different starting point.